Send a Greeting Card
The CyberKnife is the first and only robotic stereotactic radiosurgery system designed
to treat tumors anywhere in the body, including the brain, spine, lung, kidney,
liver, pancreas and prostate. It delivers high doses of radiation with pin-point,
sub-millimeter accuracy. Because the CyberKnife System can deliver radiation beams
from virtually any direction, the radiation beams are focused precisely on the tumor,
minimizing damage to the surrounding healthy tissue and nearby critical structures
like the spinal cord or optic nerve.
Conventional radiation therapy (radiotherapy) administers a broad beam of radiation
from one to two directions in 30 to 45 treatments. It delivers low-dose beams of
radiation over a period of 6 to 8 weeks – the time required to allow healthy tissue
damaged during treatment to recover.
CyberKnife radiosurgery delivers high-dose beams of radiation – which can be more
effective in killing tumors anywhere in the body. This system can deliver radiation
beams from virtually unlimited directions with sub-millimeter accuracy. With radiosurgery,
damage to surrounding healthy tissue is minimized; therefore, the treatment can be
completed typically in one to five sessions.
Head and Neck Radiosurgery
Skull Base Radiosurgery
Pancreas and Renal RadiosurgeryProstate RadiosurgerySkeletal Metastasis (Other tumors and conditions anywhere in the
body where radiation treatment is indicated.)
In most patients there are minimal to no side effects associated with CyberKnife
treatments. Your doctor can advise you of possible adverse effects based on your
type of cancer and your specific treatment plan.
Currently, more than 70,000 patients have been treated worldwide by the
Accuray® has given cancer patients
another treatment option with the development of the world’s first and only dedicated
radiosurgery device: The CyberKnife Robotic Stereotactic Radiosurgery System. With
the CyberKnife system, radiosurgery is no longer limited to treating tumors in the
head and neck.
Yes, the Food and Drug Administration (FDA) cleared the CyberKnife System for the
treatment of tumors in the head, neck and upper spine in 1999, and for the treatment
tumors anywhere in the body where radiation is indicated in 2001.
While Accuray cannot guarantee reimbursement from any third-party payer, data collected
from U.S.-based CyberKnife centers indicate that more than 100 unique commercial
and private payers are reimbursing the related codes and any or all portions of
the CyberKnife services. Patients should always consult with a physician in connection
with any and all treatment options and obtain prior authorization from their insurance
companies once a treatment option is determined.
CyberKnife TherapySaint Peter's University Hospital
254 Easton Avenue
New Brunswick, NJ 08901
Patient Compass Portal
My Saint Peter's
© 2013 Saint Peter’s Healthcare System254 Easton Avenue, New Brunswick, NJ 08901